. . . . . . . "[These findings support future applications of hPNPase(old-35) for targeted gene-based therapy of neuroblastoma and suggest that combination with the PEG-3 promoter holds promise for creating a potent and selective neuroblastoma therapeutic.J.Cell.Physiol.219: 707-715, 2009.(c) 2009 Wiley-Liss, Inc.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:16+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .